iqvia glp-1 prescriptions q3 2024 semaglutide tirzepatide Momentum is building for oral Wegovy. Data from shows 3,071 U.S. in its first four days on the market. Investors are watching closely to see if Novo Nordisk can gain Impact of the CVS GLP-1

Providers can customize the program to fit their practices specific needs, adjusting everything from the educational content to daily tasks that keep patients accountable

In short, while both Semaglutide and Tirzepatide are effective, Tirzepatides extra boost makes it the superior choice for faster, more sustained results and in our clinical experience far less side effects

This prevents the metabolic adaptation that causes stalls

Tchang BG, Aras M, Kumar RB, et al

However, this MDL will solely be for people who took a GLP-1 (like Mounjaro) and developed a rare eye stroke called non-arteritic anterior ischemic optic neuropathy (NAION)